Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
FS-118 by F-star Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
FS-118 is under clinical development by F-star Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...
Data Insights
FS-118 by F-star Therapeutics for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
FS-118 is under clinical development by F-star Therapeutics and currently in Phase II for Diffuse Large B-Cell Lymphoma. According to...